News

CAMC Interventional Radiology has introduced a new minimally invasive procedure to treat cancer through a needle.

Cardiologists at CAMC are using a new therapy for the treatment of the most dangerous types of heart attack.

This is a new treatment option for people who suffer from obstructive sleep apnea and cannot use CPAP therapy.

CAMC is excited to now offer the first FDA-approved targeted radioligand therapy for eligible prostate cancer patients.

Patients suffering from liver cancer now have a new, targeted, minimally invasive treatment option at CAMC.

This monetary support will help fund projects that both expand and upgrade services offered at CAMC.

Amy Deipolyi, MD, PhD, recently joined the CAMC Vascular Center of Excellence specializing in both interventional and diagnostic radiology.

At CAMC, a specialized team uses a multidisciplinary approach to treat patients with AVMs, using a personalized plan to treat...

CAMC has recently expanded its cardiac imaging capabilities in an effort to diagnose and treat cardiovascular disease and provide the...